SurModics Inc (SRDX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:SurModics Inc (SRDX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7279
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SurModics Inc (SurModics) is a provider of device drug delivery coating and in vitro diagnostic technologies. The company offers wide range of advanced technologies that includes medical device coating technologies and surface modification coating technologies. Its technologies are employed in the development of new medical devices, biomedical products and in the enhancement of existing products and devices. SurModics commercializes its technologies through licensing and royalty arrangements with medical device manufacturers. SurModics sells components for in vitro diagnostic test kits and microarrays; and manufactures and distributes surface coatings to the diagnostic and biomedical research markets. The company has a wide distribution network across the world. SurModics is headquartered in Minnesota, the US.

SurModics Inc (SRDX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SurModics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SurModics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
SurModics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SurModics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
SurModics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
SurModics Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Surmodics to Acquire Thrombectomy Technology Assets from Embolitech 10
Partnerships 11
Abbott Lab Enters into Licensing Agreement with SurModics 11
Acquisition 12
SurModics Acquires NorMedix for USD14 Million 12
SurModics Acquires Creagh Medical 13
SurModics Inc – Key Competitors 14
SurModics Inc – Key Employees 15
SurModics Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 18
Financial Announcements 18
Aug 06, 2018: Surmodics reports third quarter fiscal 2018 results 18
May 02, 2018: Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance 19
May 02, 2018: CORRECTING and REPLACING Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance 20
Feb 08, 2018: Surmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 Guidance 21
Nov 08, 2017: Surmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 Guidance 22
Aug 03, 2017: Surmodics Reports Third Quarter Fiscal 2017 Results and Updates Fiscal 2017 Guidance 23
Apr 27, 2017: Surmodics Reports Second Quarter Fiscal 2017 Results, Updates Fiscal 2017 Financial Guidance 24
Apr 17, 2017: Surmodics Appoints Lisa Wipperman Heine to Its Board of Directors 25
Feb 02, 2017: Surmodics Reports First Quarter Fiscal 2017 Results 26
Corporate Communications 28
May 16, 2018: Surmodics Announces Leadership Change and Appointment of Interim CFO 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
SurModics Inc, Medical Equipment, Key Facts, 2017 2
SurModics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
SurModics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SurModics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
SurModics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SurModics Inc, Deals By Market, 2012 to YTD 2018 8
SurModics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Surmodics to Acquire Thrombectomy Technology Assets from Embolitech 10
Abbott Lab Enters into Licensing Agreement with SurModics 11
SurModics Acquires NorMedix for USD14 Million 12
SurModics Acquires Creagh Medical 13
SurModics Inc, Key Competitors 14
SurModics Inc, Key Employees 15
SurModics Inc, Other Locations 16
SurModics Inc, Subsidiaries 16

List of Figures
SurModics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
SurModics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
SurModics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
SurModics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
SurModics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SurModics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
SurModics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SurModics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[SurModics Inc (SRDX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sinopec Shanghai Petrochemical Company Limited:企業の戦略・SWOT・財務情報
    Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Perenco Holdings:企業の戦略的SWOT分析
    Perenco Holdings - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Regen BioPharma Inc (RGBP):製薬・医療:M&Aディール及び事業提携情報
    Summary Regen BioPharma Inc (Regen BioPharma), a subsidiary of Bio-Matrix Scientific Group Inc, is an immunology and immunotherapy space provider. The company concentrates on the development of immunotherapies and cancer stem cell therapies. Its product pipeline includes HemaXellerate, dCellVax, Dif …
  • DexCom Inc (DXCM):企業の製品パイプライン分析
    Summary Dexcom Inc (Dexcom) is a medical device company that designs, develops and commercializes continuous glucose monitoring (CGM) systems. The company’s major products include integrated CGM systems for adults and pediatric use, Dexcom G5 mobile CGM system, Dexcom G4 PLATINUM CGM system, associa …
  • British Business Bank Plc:企業の戦略的SWOT分析
    British Business Bank Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • PRA Health Sciences Inc (PRAH)-製薬・医療分野:企業M&A・提携分析
    Summary PRA Health Sciences Inc (PRA) is a contract research organization(CRO) which provides clinical development services. The company offers services such as phase I-IV study management, and embedded and functional outsourcing services. It offers solutions in bioanalytical laboratories, biometric …
  • Datang International Power Generation Co Ltd:企業の発電所・SWOT分析2018
    Datang International Power Generation Co Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inf …
  • Targovax ASA (TRVX):企業の財務・戦略的SWOT分析
    Summary Targovax ASA (Targovax) is a developer and commercializer of immunotherapies for the treatment of cancer patients. The company’s lead candidates include TG0, a peptide-based therapeutic anti-cancer vaccine under development for pancreatic cancer; and ONCOS-102 is an adenovirus-based pipeline …
  • Pharming Group NV (PHARM):企業の財務・戦略的SWOT分析
    Pharming Group NV (PHARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Volvo Car Corporation:企業の戦略・SWOT・財務分析
    Volvo Car Corporation - Strategy, SWOT and Corporate Finance Report Summary Volvo Car Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Otto Energy Ltd (OEL):石油・ガス:M&Aディール及び事業提携情報
    Summary Otto Energy Ltd (Otto Energy), formerly Ottoman Energy Ltd, is an oil and gas company that offers exploration, production, and development of oil and gas properties. The company's products include oil and gas. It operates its exploration properties located in the Offshore Gulf of Mexico such …
  • Genesis Healthcare, Inc.:戦略・SWOT・企業財務分析
    Genesis Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report Summary Genesis Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Arch Capital Group Ltd.:企業の戦略・SWOT・財務情報
    Arch Capital Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Arch Capital Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Mars Incorporated:企業の戦略的SWOT分析
    Mars Incorporated - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Texas Roadhouse Inc (TXRH):企業の財務・戦略的SWOT分析
    Texas Roadhouse Inc (TXRH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Cycle Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Cycle Pharmaceuticals Ltd (Cycle) focuses on the development of pharmaceutical products. It acquires, redevelop, and relaunch pharmaceuticals that have been previously marketed. It spans expertise in improving orphan drugs to treat rare diseases. Cycle’s lead drug product includes NITYR (nit …
  • Compania Minera Autlan SAB de CV:企業の戦略・SWOT・財務情報
    Compania Minera Autlan SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Compania Minera Autlan SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • PacWest Bancorp:企業の戦略・SWOT・財務情報
    PacWest Bancorp - Strategy, SWOT and Corporate Finance Report Summary PacWest Bancorp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Hedberg Landscape & Masonry Supplies:企業の戦略的SWOT分析
    Hedberg Landscape & Masonry Supplies - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • TIS Inc (3626):企業の財務・戦略的SWOT分析
    TIS Inc (3626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆